Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan
- 1 August 2006
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (6) , 671-675
- https://doi.org/10.1016/j.ejso.2006.03.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Peritonectomy proceduresSurgical Oncology Clinics of North America, 2003
- Cytoreductive Surgery Followed by Intraperitoneal Hyperthermic Perfusion in the Treatment of Recurrent Epithelial Ovarian Cancer: A Phase II Clinical StudyTumori Journal, 2001
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Second-look laparotomy and salvage therapy: A research modality only?Gynecologic Oncology, 1992
- Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaGynecologic Oncology, 1989
- Survival after second-look laparotomy in advanced ovarian epithelial cancer: Study of 86 patientsEuropean Journal of Cancer and Clinical Oncology, 1989
- Evaluation of treatment and survival after positive second-look laparotomyGynecologic Oncology, 1988
- The treatment of advanced ovarian carcinoma (II): Interval reassessment operations during chemotherapyGynecologic Oncology, 1988
- Prognosis of surgically determined complete responders in advanced ovarian cancerCancer, 1985
- The general rules for the gastric cancer study in surgery and pathologySurgery Today, 1981